Skip to the page

Data / Form D filings / Escalante Bioscience, Inc.

Escalante Bioscience, Inc.: Form D filing

Escalante Bioscience, Inc., a health care company in San Francisco, CA, filed a Form D with the SEC in 2024. The latest, on May 17, 2024, reports $6.7 million sold of a $6.7 million offering to 17 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
953 INDIANA ST., San Francisco, CA, 94107
Phone
(415) 275-0404
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2023832

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 17, 2024New notice$6,749,986$6,749,98617May 7, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Akshay R TambeDirector
April D SchleckExecutive Officer, Director
Ching-Yun HsuExecutive Officer, Director
Nicholas R BoydDirector

Other health care companies in California that filed recently

Every Form D from the week of May 13, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Escalante Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.